Loading…
Check-Cap Ltd. is projected to rise to $1.55 by 2027, a +37% move from its current price of $1.13. MBAI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.08 | $1.13 | $1.19 | -0.04% |
| Aug 6 | $1.05 | $1.13 | $1.21 | -0.09% |
| Aug 7 | $1.04 | $1.13 | $1.23 | -0.13% |
| Aug 8 | $1.02 | $1.13 | $1.24 | -0.18% |
| Aug 9 | $1.01 | $1.13 | $1.26 | -0.22% |
| Aug 10 | $1.00 | $1.13 | $1.27 | -0.27% |
| Aug 11 | $0.9912 | $1.13 | $1.28 | -0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.9912 | $1.13 | $1.28 | -0.31% |
| Week 2 | $0.9371 | $1.12 | $1.35 | -0.62% |
| Week 3 | $0.897 | $1.12 | $1.40 | -0.93% |
| Week 4 | $0.8641 | $1.12 | $1.44 | -1.24% |
| Week 5 | $0.8358 | $1.11 | $1.48 | -1.55% |
| Week 6 | $0.8107 | $1.11 | $1.52 | -1.86% |
| Week 7 | $0.7882 | $1.11 | $1.55 | -2.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Check-Cap Ltd. is a clinical stage medical diagnostics company focused on capsule-based screening technology for detection of precancerous colorectal polyps.
Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
It is categorized in Healthcare.
Check-Cap Ltd. (MBAI) is currently trading at $1.07.
Its market capitalization is $8.27M and it is ranked 4969.
The 30-day range runs from $0.7347 to $1.56, with RSI14 of 40, SMA50 of $1.39, and SMA200 of $1.61. The stock has support at $0.95 and resistance at $1.44. Annualized volatility is 100%.
Forecasts show a bullish trajectory beyond 2026, with the average price rising in the years that follow and a long-run potential to reach $4.20 on average by 2050; notable year-by-year markers include 2027 avg $1.52 (ROI 42.2%), 2028 avg $1.79 (ROI 67.2%), 2030 avg $1.69 (ROI 58.2%), and 2050 avg $4.20 (ROI 292.2%).
A major floor 41.0% below — a decisive break under it would weaken the trend.
The nearest floor, 15.9% below — buyers have tended to step in here.
The nearest ceiling, 26.5% above — a clean break opens room to run.
A major ceiling 77.0% above — clearing it would confirm fresh momentum.
Key MBAI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MBAI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.06 | Buy | $1.06 | Buy |
| MA 10 | $1.05 | Buy | $1.07 | Buy |
| MA 20 | $1.08 | Buy | $1.10 | Buy |
| MA 50 | $1.31 | Sell | $1.26 | Sell |
| MA 100 | $1.48 | Sell | $1.40 | Sell |
| MA 200 | $1.59 | Sell | $1.45 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.33 | Neutral |
| Stoch RSI (14) | 69.33 | Neutral |
| CCI (20) | -25.49 | Neutral |
| Williams %R (14) | -50.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 4.95 | Buy |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 50.00 | Neutral |
| TRIX (15) | -0.98 | Sell |
| Awesome (5,34) | -0.11 | Sell |
| Ultimate (7,14,28) | 50.95 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 1.05 | Buy |
| ADX (14) | 19.42 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is NEUTRAL with RSI14 at 40.
Price is below both the SMA50 ($1.39) and SMA200 ($1.61), indicating near-term softness relative to medium- and long-term averages.
Support sits at $0.95 and resistance at $1.44, framing a near-term range. The 30-day price range is $0.7347 to $1.56, reflecting modest volatility in the window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.95 | $1.13 | $1.64 | 0% | Neutral | |
| $1.15 | $1.55 | $2.25 | +37% | Bullish | |
| $1.23 | $1.74 | $2.69 | +54% | Bullish | |
| $1.12 | $1.67 | $2.70 | +48% | Bullish | |
| $1.10 | $1.70 | $2.86 | +51% | Bullish | |
| $0.9473 | $1.53 | $2.65 | +35% | Bullish | |
| $0.8655 | $1.45 | $2.59 | +28% | Bullish | |
| $0.9353 | $1.62 | $2.97 | +44% | Bullish | |
| $1.08 | $1.93 | $3.62 | +71% | Bullish | |
| $1.27 | $2.36 | $4.53 | +109% | Bullish | |
| $1.03 | $2.24 | $4.68 | +98% | Bullish | |
| $1.88 | $4.18 | $9.61 | +270% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.95 | $1.13 | $1.42 | +0.00% |
| September 2026 | $0.9579 | $1.16 | $1.46 | +2.48% |
| October 2026 | $0.8863 | $1.08 | $1.39 | -6.31% |
| November 2026 | $0.9034 | $1.12 | $1.45 | +2.99% |
| December 2026 | $0.9951 | $1.24 | $1.64 | +11.19% |
Click any year to see its month-by-month MBAI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, MBAI is projected to trade between $0.95 and $1.64, averaging $1.13 — a potential gain of 0% from today's $1.13. Price action looks broadly range-bound.
Check-Cap Ltd.'s 2027 outlook centres on $1.55, within a $1.15 to $2.25 range. That is up +37% on the projected 2026 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, MBAI could reach as high as $2.69, with a base case around $1.74 and support toward $1.23 — roughly +54% from $1.13. Momentum favours further upside here.
Expect MBAI to range from $1.12 to $2.70 through 2029. The $1.67 average target implies a +48% move from current prices. That is -4% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
The MBAI price prediction for 2030 points to an average of $1.70 (low $1.10, high $2.86) — a potential gain of +51% on today's $1.13. Momentum favours further upside here.
In 2031, MBAI is projected to trade between $0.9473 and $2.65, averaging $1.53 — a potential gain of +35% from today's $1.13. That is -10% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
Check-Cap Ltd.'s 2032 outlook centres on $1.45, within a $0.8655 to $2.59 range. That is -5% versus the projected 2031 average. That marks a +28% change versus current levels. Momentum favours further upside here.
By 2033, MBAI could reach as high as $2.97, with a base case around $1.62 and support toward $0.9353 — roughly +44% from $1.13. Buyers look set to stay in control over this stretch.
Expect MBAI to range from $1.08 to $3.62 through 2034. The $1.93 average target implies a +71% move from current prices. That is up +19% on the projected 2033 average. Momentum favours further upside here.
The MBAI price prediction for 2035 points to an average of $2.36 (low $1.27, high $4.53) — a potential gain of +109% on today's $1.13. Buyers look set to stay in control over this stretch.
In 2040, MBAI is projected to trade between $1.03 and $4.68, averaging $2.24 — a potential gain of +98% from today's $1.13. That is -5% versus the projected 2035 average. Momentum favours further upside here.
Check-Cap Ltd.'s 2050 outlook centres on $4.18, within a $1.88 to $9.61 range. That is up +87% on the projected 2040 average. That marks a +270% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in MBAI today (≈ 884.955752 MBAI) could be worth
$3,698.02
+$2,698.02 (+270%) by 2050 · US Dollar
Based on the average projected MBAI price of $4.18 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MBAIwould be worth at today's price.
$1,000 invested in MBAI on Jul 31, 2025 (≈ 1,351.351334 MBAI) would be worth
$1,527.03
+$527.03 (+52.7%) today · 1.53× · US Dollar
Based on a MBAI entry price of $0.74 vs. today's $1.13.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.1 | $1,027.27 | +2.7% |
| 1 month ago | $1.24 | $911.29 | -8.9% |
| 3 months ago | $1.45 | $779.31 | -22.1% |
| 6 months ago | $1.45 | $779.31 | -22.1% |
| 1 year ago | $0.74 | $1,527.03 | +52.7% |
| All time (5.0y) ago | $21.8 | $51.83 | -94.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MBAI forecast.
Our base-case forecast reaches $2.30 around 2035.
Implied market cap at $2.30: $17.78M
The multi-year forecast leans bullish from 2027 onward, with rising price averages and substantial upside in later years.
2030: average price $1.69, ROI 58.2%.
2040: average price $2.20, ROI 106%.
2050: average price $4.20, ROI 292.2%.
These figures illustrate a trajectory of increasing value over the long horizon, tempered by inherent uncertainty and the usual risks associated with clinical-stage biotechnology and diagnostic equities.
Tap a question to reveal the answer.
2030 avg $1.69, min $1.05, max $2.93; ROI 58.2%; sentiment BULLISH.
Forecasts show bullish sentiment in multiple years with rising averages (e.g., 2027 avg $1.52; 2028 avg $1.79; 2030 avg $1.69; 2050 avg $4.20) and ROIs such as 42.2% in 2027, 67.2% in 2028, 58.2% in 2030, and 292.2% in 2050. These are estimates, not guarantees.
2035 max price is $4.83; avg $2.42; min $1.22; ROI 126%.
Current price is $1.07; Market capitalization is $8.27M.
RSI14 is 40; SMA50 is $1.39; SMA200 is $1.61; 30-day range is $0.7347 to $1.56; support is $0.95; resistance is $1.44.
Check-Cap Ltd. Community Discussion
0Share your Check-Cap Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.